Jing Cui, DSc, DABR

Title(s)Assistant Professor of Clinical Radiation Oncology
SchoolKeck School of Medicine of Usc
AddressGNH 1100 N. State Street
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 409 1383
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    AAPM2009AAPM Summer School Scholarship & Capintec Travel Award

    Collapse Overview 
    Collapse Overview
    Dr. Cui is an Assistant Professor of Clinical Radiation Oncology-Medical Physics at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. She joined USC in July of 2014.

    Dr. Cui graduated from Shanghai Jiao Tong University in China with a Bachelor of Science degree in Mechanical Engineering and Minor in Applied Mathematics. She received her doctorate degree from Washington University in St. Louis School of Engineering and Applied Science, and conducted post-doctoral research in Medical Physics at Washington University in St. Louis followed by a two-year residency in Medical Physics at UC Davis.

    She was on the faculty at UC Davis during 2010-2014 specializing in medical linear accelerator commissioning, radiation beam modeling, and image-guided radiation therapy. She has presented and published multiple studies investigating computational fluid dynamics, radiation beam modeling, IGRT, and is a reviewer for multiple peer reviewed scientific journals.

    Medical Physics Expertise: IGRT, Radiation Beam Modeling, SBRT, HDR

    Languages Spoken: English, Mandarin

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Automatic segmentation of high-risk clinical target volume for tandem-and-ovoids brachytherapy patients using an asymmetric dual-path convolutional neural network. Med Phys. 2022 Mar; 49(3):1712-1722. Cao Y, Vassantachart A, Ragab O, Bian S, Mitra P, Xu Z, Gallogly AZ, Cui J, Shen ZL, Balik S, Gribble M, Chang EL, Fan Z, Yang W. PMID: 35080018; PMCID: PMC9170543.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    2. Momentum-space imaging spectroscopy for the study of nanophotonic materials. Sci Bull (Beijing). 2021 Apr 30; 66(8):824-838. Zhang Y, Zhao M, Wang J, Liu W, Wang B, Hu S, Lu G, Chen A, Cui J, Zhang W, Hsu CW, Liu X, Shi L, Yin H, Zi J. PMID: 36654139.
      View in: PubMed   Mentions: 3     Fields:    
    3. Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain. J Med Chem. 2018 08 09; 61(15):6779-6800. Bagal SK, Andrews M, Bechle BM, Bian J, Bilsland J, Blakemore DC, Braganza JF, Bungay PJ, Corbett MS, Cronin CN, Cui JJ, Dias R, Flanagan NJ, Greasley SE, Grimley R, James K, Johnson E, Kitching L, Kraus ML, McAlpine I, Nagata A, Ninkovic S, Omoto K, Scales S, Skerratt SE, Sun J, Tran-Dubé M, Waldron GJ, Wang F, Warmus JS. PMID: 29944371.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    4. Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations. Med Phys. 2016 Aug; 43(8):4842. Davidson SE, Cui J, Kry S, Deasy JO, Ibbott GS, Vicic M, White RA, Followill DS. PMID: 27487902; PMCID: PMC4967077.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck. J Med Imaging Radiat Oncol. 2014 Oct; 58(5):618-24. Kishan AU, Cui J, Wang PC, Daly ME, Purdy JA, Chen AM. PMID: 24942938.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    6. Helical tomotherapy with simultaneous integrated boost dose painting for the treatment of synchronous primary cancers involving the head and neck. Br J Radiol. 2014 Aug; 87(1040):20130697. Chen AM, Daly ME, Cui J, Wooten HO, Farwell DG, Purdy JA. PMID: 24884726; PMCID: PMC4112398.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):771-7. Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA. PMID: 24606846.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    8. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning. Head Neck. 2014 Nov; 36(11):1541-6. Chen AM, Daly ME, Cui J, Mathai M, Benedict S, Purdy JA. PMID: 23996502.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    9. Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours. Br J Radiol. 2013 Dec; 86(1032):20130459. Batth SS, Sreeraman R, Dienes E, Beckett LA, Daly ME, Cui J, Mathai M, Purdy JA, Chen AM. PMID: 24167183; PMCID: PMC3856547.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    10. Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target? Int J Gynecol Cancer. 2013 Feb; 23(2):385-92. Rash D, Hagar Y, Cui J, Hunt JP, Valicenti R, Mayadev J, Department of Radiation Oncology, University of California, Davis, Cancer Center, Sacramento, CA. PMID: 23287959.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    11. Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e45-53. Healy E, Anderson S, Cui J, Beckett L, Chen AM, Perks J, Stern R, Mayadev J. PMID: 24674320.
      View in: PubMed   Mentions: 9     Fields:    
    12. Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor. Mol Cancer Ther. 2012 Apr; 11(4):1036-47. Zou HY, Li Q, Lee JH, Arango ME, Burgess K, Qiu M, Engstrom LD, Yamazaki S, Parker M, Timofeevski S, Cui JJ, McTigue M, Los G, Bender SL, Smeal T, Christensen JG. PMID: 22389468.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    13. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):376-82. Yi SK, Mak W, Yang CC, Liu T, Cui J, Chen AM, Purdy JA, Monjazeb AM, Do L. PMID: 22342301.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    14. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1897-902. Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK. PMID: 21536391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. MicroRT-small animal conformal irradiator. Med Phys. 2007 Dec; 34(12):4706-16. Stojadinovic S, Low DA, Hope AJ, Vicic M, Deasy JO, Cui J, Khullar D, Parikh PJ, Malinowski KT, Izaguirre EW, Mutic S, Grigsby PW. PMID: 18196798.
      View in: PubMed   Mentions: 44     Fields:    Translation:Animals
    16. The denoising of Monte Carlo dose distributions using convolution superposition calculations. Phys Med Biol. 2007 Sep 07; 52(17):N375-85. El Naqa I, Cui J, Lindsay P, Olivera G, Deasy JO. PMID: 17762073.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    17. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res. 2007 May 01; 67(9):4408-17. Zou HY, Li Q, Lee JH, Arango ME, McDonnell SR, Yamazaki S, Koudriakova TB, Alton G, Cui JJ, Kung PP, Nambu MD, Los G, Bender SL, Mroczkowski B, Christensen JG. PMID: 17483355.
      View in: PubMed   Mentions: 279     Fields:    Translation:HumansAnimalsCells
    18. Retrospective monte carlo dose calculations with limited beam weight information. Med Phys. 2007 Jan; 34(1):334-46. Lindsay PE, El Naqa I, Hope AJ, Vicic M, Cui J, Bradley JD, Deasy JO. PMID: 17278519.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. In vivo models of proliferative vitreoretinopathy. Nat Protoc. 2007; 2(1):67-77. Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR. PMID: 17401340.
      View in: PubMed   Mentions: 62     Fields:    Translation:AnimalsCells
    20. Three-dimensional computation of a synthetic jet in quiescent air. AIAA Journal. 2006; 44(12):2857-2865. Cui J., Agarwal R. View Publication.
    21. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 2003 Nov 01; 63(21):7345-55. Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, Le P, Chen J, Wang X, Ruslim L, Blake R, Lipson KE, Ramphal J, Do S, Cui JJ, Cherrington JM, Mendel DB. PMID: 14612533.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansAnimalsCells
    22. Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors. Bioorg Med Chem Lett. 2003 Jun 02; 13(11):1939-42. Li X, Huang P, Cui JJ, Zhang J, Tang C. PMID: 12749903.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    23. A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. Am J Hum Genet. 2003 Jun; 72(6):1515-26. Sun F, Cui J, Gavras H, Schwartz F. PMID: 12730827; PMCID: PMC1180311.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    24. Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates. Bioorg Med Chem Lett. 2002 Apr 22; 12(8):1203-8. Reiner JE, Siev DV, Araldi GL, Cui JJ, Ho JZ, Reddy KM, Mamedova L, Vu PH, Lee KS, Minami NK, Gibson TS, Anderson SM, Bradbury AE, Nolan TG, Semple JE. PMID: 11934589.
      View in: PubMed   Mentions:    Fields:    Translation:Animals